The cDNA for the full-length core protein of the small chondroitin sulphate proteoglycan II of bovine bone was cloned and sequenced. A 1.3 kb clone (APg28) was identified by plaque hybridization with a previously isolated 1.0 kb proteoglycan cDNA clone (APg2O), positively identified previously by polyclonal and monoclonal antibody reactivity and by hybrid-selected translation in vitro [Day, Ramis, Fisher, Gehron Robey, Termine & Young (1986) Nucleic Acids Res. 14, 9861-9876]. The cDNA sequences of both clones were identical in areas of overlap. The 360-amino-acid-residue protein contains a 30-residue propeptide of which the first 15 residues are highly hydrophobic. The mature protein consists of 330 amino acid residues corresponding to an Mr of 36383. The core protein contains three potential glycosaminoglycan-attachment sites (Ser-Gly), only one of which is within a ten-amino-acid-residue homologous sequence seen at the known attachment sites of related small proteoglycans. Comparisons of the published 24-residue N-terminal protein sequence of bovine skin proteoglycan II core protein with the corresponding region in the deduced sequence of the bovine bone core protein reveals complete homology. Comparison of the cDNA-derived sequences of bovine bone and human embryonic fibroblast proteoglycans shows a hypervariable region near the N-terminus. Nucleotide homology between bone and fibroblast core proteins was 87 %, and amino acid homology was 90 %.
INTRODUCTION
Biological functions for proteoglycans (PGs) may be as diverse as the tissues in which they are found. These functions include conferment of compressive properties to cartilage [1, 2] , interaction with collagen fibrils during fibrillogenesis [2] [3] [4] , stabilization ofbasement membranes and other connective tissues [5] [6] [7] and the regulation of biological clocks [8] . The small proteoglycans of bone [5, 9, 10] are typically representative of one form of these macromolecules, as they appear in a variety ofconnective tissues [10] . We previously isolated cDNA clones for the most abundant bone proteoglycan (PG-Il) and determined the distribution of its mRNA in relation to that of small proteoglycans in skin, cornea, smooth muscle, articular cartilage and tendon [11] . Our studies also found that PG-1I expression was sensitive to viral transformation, as are those of other connective-tissue proteins [11] . In the present paper we describe the complete primary sequence of the bovine bone PG-II core protein, deduced from these cDNA clones, and compare it with those of other proteoglycan core proteins from bovine skin [12, 13] and human placenta [14, 15] .
MATERIALS AND METHODS Screening of the bacteriophage library
The isolation, purification and partial characterization of the APg2O cDNA was reported previously [11] . Insert from the 1.0 kb cDNA clone was nick-translated (Amersham), and 3.2 x I07 c.p.m. was used to rescreen a previously constructed bovine bone Agtl 1 cDNA library [16] by the plaque hybridization method of Young & Davis [17] . Of the 40000 recombinants screened, 75 positive clones were identified and eight were rescreened to purity. Isolation of selected insert clones by EcoRI digestion and agarose-gel electrophoresis [18] were performed. Clone APg28 was selected for its size (1.3 kb), which closely correlated with the estimated size of the mRNA for the core protein of bovine bone PG-II [11] . Subcloning and sequence determination Inserts for APg2O and APg28 were subcloned into Ml3mpl8 and Ml3mpl9 bacteriophage sequencing vectors. The sequencing strategy consisted of (A) ordered fragment sequencing with the use of subcloned restriction fragments of the inserts, (B) M 13 rapid deletion subcloning (Cyclone System, IBI) and (C) utilization of synthetic 17-mer and 20-mer oligonucleotides based upon sequence derived from methods A and B. The oligonucleotides were synthesized on a DNA synthesizer 380B (Applied Biosystems). The sequences of the oligonucleotides are as follows from 5' to 3':   MY18, TGGTGATTTTGTTGCCA  MY19, GATTGCAGAGATATTGTTG  MY20, ACTTTAAGAACCTGAAGAAC  MY21, CTCTTCAGGAGCTGCGTGTC  MY22, CCATTTTCAATGCCTGAGCT  MY23, TCCGATGTGTCTATGTGCGT  MY24, TTATAAAAATGAGGGTTTTC  MY25, [11] by immunoscreening and was used to confirm and complement the sequence derived from APg28. Determination of the nucleotide sequence
The restriction map analysis of APg2O and APg28 as well as the sequencing strategy are shown in Fig. 1 . The complete coding sequence of the protein was determined by sequencing both strands by utilizing restrictionenzyme-generated fragments of clones and synthetic oligonucleotides (20-mers) derived from these sequences.
The results generated a continuous cDNA sequence of 1250 bases including 5' and 3' flanking sequences (Fig.  2) . The ATG initiation codon is preceded by 87 nucleotide residues containing two termination codons in the same reading frame. The coding region of the cDNA consists of 1080 bases corresponding to 360 amino acid residues. The termination codon (TAG) occurs at bases 1168-1170. A potential polyadenylation signal, ATAA, is 23 bases downstream of the stop codon and 30 bases upstream of the poly(A) tail. Analysis of the deduced core protein of PG-i Analysis of hydropathy for the deduced amino acid sequence showed an N-terminal 15-amino-acid-residue hydrophobic region typical of a signal peptide [20] . A comparison of this amino acid sequence with published N-terminal core protein sequences for the small proteoglycans of bovine skin [12, 13] and human bone [9] reveals an additional 15 N-terminal amino acid residues that are not part of the secreted tissue protein and that may represent a propeptide. Three possible glycosaminoglycan-attachment sites (Ser-Gly) are present in the protein, at Ser-4, Ser-160 and Ser-296. There were three potential acceptor sites for asparagine (N)-linked glycosylation, located at Asn-182, Asn-233 and Asn-274, all in the latter half of the protein.
The predicted 360-amino-acid-residue precursor pro- chondroitin sulphate PG-II of bovine bone with the nucleotide sequence of the dermatan sulphate proteoglycan expressed in human fibroblasts [14] reveals a 52 % homology in the 5' untranslated region and an 82% homology of 82 bases of the 3' flanking sequences. The coding regions of these two proteins display an 87% homology at the nucleotide level and a 90 % homology at the amino acid level (Fig. 3 ). There is an 11-aminoacid-residue hypervariable region (9 % homology between the two core proteins) (residues 10-20 of the secreted protein). The signal-peptide regions are 90 % homologous. Comparison of these sequences with the Nterminal amino acid residues of the core proteins from bovine skin [12] and tendon [21] proteodermatan sulphates shows complete homology between the bovine skin and bone species (Fig. 3 ).
DISCUSSION
We have isolated cDNA clones for the small proteoglycan IT of bovine bone from a Agtl 1 bovine bone cell library by using a combination of immunoscreening and plaque hybridization. We report here the complete cDNA coding sequence and the deduced amino acid sequence of the core protein.
The core protein contains a 30-amino-acid-residue propeptide, of which the first 15 residues are highly hydrophobic and probably represent a signal peptide. The mature core protein is 330 amino acid residues long and has an Mr of 36383. The tetrapeptide Ser-Gly-XaaGly has been reported to be a recognition consensus sequence for glycosaminoglycan chain attachment to proteoglycan core proteins [22] . This consensus sequence occurs at only one of the three Ser-Gly repeats in bone PG-TI and agrees with the observations by Chopra et al. [13] of Ser-4 as the site of glycosaminoglycan chain attachment for skin proteodermatan sulphate. The bone PG-IT molecule is known to have one chain per molecule [23] , and the adjacent amino acid sequence (Asp-GluAla-Ser-Gly-Ile-Gly-Pro-Glu) is the same as that reported for the bovine skin, bovine tendon and human fetal membrane proteoglycan core proteins [13, 14, 21] . It is likely that the bovine bone protein also has an attached glycosaminoglycan chain at this site. Our deduced amino acid sequence reveals four cysteine residues closely aligned in the N-terminal region of the PG-II core protein and two at the C-terminus. Fisher et al. [5] reported the presence of at least one N-linked oligosaccharide in bovine bone PG-TI. There were three potential acceptor sites for N-linked glycosylation in the latter half of the protein.
Our deduced protein sequence was compared with a recently cloned chondroitin/dermatan sulphate proteoglycan expressed by a human embryonic fibroblast cell line [14] . The two sequences were 87 % homologous at the nucleotide level and 90 % homologous at the protein level. The sequence obtained here for the bovine bone core protein was identical with that reported for the 24-residue N-terminus of bovine skin proteoglycan [12] and the 14-residue N-terminus of bovine tendon proteoglycan [21] . Therefore the hypervariable region (residues 10-20 of the secreted protein) may reflect species differences. Alternatively, since the human fibroblast proteoglycan was derived from transformed cells, sequence variability might also arise from transformation.
Vogel & Fisher [21] compared bovine bone, tendon and cartilage proteoglycans by immunochemical and proteolytic cleavage methods. As suggested by others [2, 10] , they found that these small proteoglycans were identical both immunochemically and on one-dimensional peptide maps [21] . However, the tendon and cartilage proteoglycans contained a major, rapid, cleavage site for Staphylococcus aureus V8 proteinase, whereas that of bovine bone did not [21] . They speculated that this major V8-proteinase site may be blocked in the bone core protein as a result of small differences either in primary structure or in post-translational modification.
Previous studies from our laboratory suggested the existence of one gene copy of PG-II core protein per haploid genome [11] . Northern-blot analyses of various bovine tissues known to contain small proteoglycans revealed similar mRNAs and demonstrated an analogous species in the human, chick and mouse [11] . The high degree of homology between bovine bone and human fibroblast core proteins strongly supports the notion of an evolutionarily conserved single-copy gene for the PG-II core protein. Subtle differences in protein structure or post-translational modification, including the type of glycosaminoglycan chains attached, may convey, however, tissue and functional specificities.
